2024-11-11 2025-11-30 true No description of principal activity Acting Office - Tax and Accounts 1.0 16072210 bus:FullAccounts 2024-11-11 2025-11-30 16072210 bus:Micro-entities 2024-11-11 2025-11-30 16072210 bus:AuditExempt-NoAccountantsReport 2024-11-11 2025-11-30 16072210 bus:SmallCompaniesRegimeForAccounts 2024-11-11 2025-11-30 16072210 bus:PrivateLimitedCompanyLtd 2024-11-11 2025-11-30 16072210 2024-11-11 2025-11-30 16072210 2025-11-30 16072210 bus:RegisteredOffice 2024-11-11 2025-11-30 16072210 core:WithinOneYear 2025-11-30 16072210 core:AfterOneYear 2025-11-30 16072210 2023-11-11 16072210 bus:Director1 2024-11-11 2025-11-30 16072210 bus:Director1 2025-11-30 16072210 bus:CompanySecretary1 2024-11-11 2025-11-30 16072210 bus:LeadAgentIfApplicable 2024-11-11 2025-11-30 16072210 2024-11-10 16072210 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 16072210 core:CostValuation core:Non-currentFinancialInstruments 2024-11-10 16072210 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 16072210 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16072210 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16072210 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16072210 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-11-30 16072210 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-11-30 16072210 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16072210 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16072210 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16072210 core:Non-currentFinancialInstruments 2025-11-30 16072210 core:Non-currentFinancialInstruments 2024-11-10 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16072210
England and Wales

 

 

 

SALI PHARMA LTD


Dormant Accounts
 


Period of accounts

Start date : 11 November 2024

End date : 30 November 2025
Director China Kang
Registered Number 16072210
Registered Office 39 Eastbury Road
Northwood
HA6 3AJ
1
 
 
 
£
2025
£
Current assets 1 
Net current assets/(liabilities) 1 
Total assets less current liabilities 1 
Net assets/(liabilities) 1 
 
Capital and reserves 1 
 



Notes to the Accounts

For the period ended 30 November 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's Responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions.
Signed on behalf of the board of directors:


---------------------------------------------
China Kang
Director

Date approved: 13 July 2026
2